Stanford researchers at the Airan Lab have developed a new deep learning approach to dramatically reduce the amount of ultrasound data required to produce high quality power Doppler images for functional ultrasound (fUS).
Stanford scientists have discovered a novel approach to address cardiovascular complications resulting from cancer chemotherapy, particularly those caused by tyrosine kinase inhibitors (TKIs).
Researchers at Stanford have developed fusion proteins, containing ACE2 domain linked to a fragment of non-neutralizing anti-SARS-CoV-2 spike protein antibody, with a greater breadth of protection than previously described similar fusion proteins.
Researchers in Prof. Karl Deisseroth's laboratory have developed a highly precise, scalable optical system for imaging or controlling thousands of individual neurons in the 3D volume accessible with a single multiphoton fluorescent microscope objective.
Researchers in Prof. Julia Salzman's laboratory have developed a sensitive, specific algorithm for automated, high-throughput detection of RNA fusions from RNA-Seq data.
Researchers in the Molecular Imaging Instrumentation Laboratory at Stanford University have developed methods to improve the image quality of tomographic image reconstruction, including positron emission tomography (PET).
Researchers at Stanford have developed an innovative molecular engineering strategy to enhance the stability and performance of polymer semiconductors (PSCs).
Stanford scientists have developed and validated a visual scoring system that enables clinicians to reliably assess skin frailty and identify patients at higher risk for complications and skin cancer.
Researchers at Stanford have developed a general software framework that reconstructs high-resolution spatial fields from sparse, irregular, or noisy measurements.
Stanford researchers have created a device with defined parallel-oriented fibrillar nanostructure that can control endothelial cell alignment along the direction of the fibrillar nanostructure.
Stanford researchers in the Cochran Lab have patented a potential pancreatic cancer therapeutic approach using novel agents that bind tightly to and inhibit a cancer factor called LIF (leukemia inhibitory factor).
Dr. Curt Scharfe and colleagues have developed RUSPseq, a method for next generation molecular testing originally conceived to diagnose metabolic disorders in newborns.
Stanford scientists have developed species cross-reactive B7H3-targeting CAR-T cells that can effectively target both human and mouse tumors, enabling more accurate preclinical testing in immunocompetent models.
Researchers in Dr. Karl Deisseroth's Lab have developed a microscope and methods to allow simultaneous recording of multiple different brain regions in a freely moving and behaving animal. Brain research is growing rapidly.
Stanford researchers have developed a wirelessly powered, fully internal implant which allows for optogenetic control of neurons throughout the nervous system in mammals, and in particular, mice.